Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction

Journal of the American College of Cardiology

Volumn 61, Issue 18, 2013, Pages 1860-1870

  Panza, Julio A ^a   Holly, Thomas A ^b   Asch, Federico M ^a   She, Lilin ^c   Pellikka, Patricia A ^d   Velazquez, Eric J ^c   Lee, Kerry L ^c   Borges Neto, Salvador ^c   Farsky, Pedro S ^e   Jones, Robert H ^c   Berman, Daniel S ^f   Bonow, Robert O ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d Mayo Clinic   (United States)

^e INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^f CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

coronary artery disease; heart failure; left ventricular dysfunction; myocardial ischemia; outcomes

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DOBUTAMINE;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC DYSFUNCTION;

CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY, STRESS; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; THROMBOLYTIC THERAPY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84876977633     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.02.014     Document Type: Article

References (31)

1. S.D. Fihn, J.M. Gardin, J. Abrams 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease J Am Coll Cardiol 60 2012 2564 2603
2. K. Fox, M.A.A. Garcia, D. Ardissino Guidelines on the management of stable angina pectoris: executive summary The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur Heart J 27 2006 1341 1381
3. M.R. Patel, G.J. Dehmer, J.W. Hirshfeld, P.K. Smith, J.A. Spertus ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography J Am Coll Cardiol 59 2012 857 881
4. D.A. Weiner, T.J. Ryan, C.H. McCabe The role of exercise testing in identifying patients with improved survival after coronary artery bypass surgery J Am Coll Cardiol 8 1986 741 748
5. L.J. Shaw, D.S. Berman, D.J. Maron Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291
6. P.A. Tonino, B. De Bruyne, N.H. Pijls Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N Engl J Med 360 2009 213 224
7. E.J. Velazquez, K.L. Lee, M.A. Deja Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 364 2011 1607 1616
8. W.E. Boden, R.A. O'Rourke, K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
9. BARI 2D Study Group R.L. Frye, P. August, M.M. Brooks et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
10. W. Hueb, N. Lopes, B.J. Gersh Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease Circulation 122 2010 949 957
11. M. Gheorghiade, G. Sopko, L. De Luca Navigating the crossroads of coronary artery disease and heart failure Circulation 114 2006 1202 1213
12. I. Afridi, P.A. Grayburn, J.A. Panza, J.K. Oh, W.A. Zoghbi, T.H. Marwick Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction J Am Coll Cardiol 32 1998 921 926
13. K.C. Allman, L.J. Shaw, R. Hachamovitch, J.E. Udelson Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis J Am Coll Cardiol 39 2002 1151 1158
14. J.J. Bax, D. Poldermans, A. Elhendy, E. Boersma, S.H. Rahimtoola Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium Curr Probl Cardiol 26 2001 147 186
15. A. Pasquet, A. Robert, A.M. D'Hondt, R. Dion, J.A. Melin, J.L. Vanoverschelde Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction Circulation 100 1999 141 148
16. R.O. Bonow, G. Maurer, K.L. Lee Myocardial viability and survival in ischemic left ventricular dysfunction N Engl J Med 364 2011 1617 1625
17. R.H. Jones, E.J. Velazquez, R.E. Michler Coronary bypass surgery with or without surgical ventricular reconstruction N Engl J Med 360 2009 1705 1717
18. E.J. Velazquez, K.L. Lee, C.M. O'Connor The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial J Thorac Cardiovasc Surg 134 2007 1540 1547
19. R.H. Jones, H. White, E.J. Velazquez STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment J Am Coll Cardiol 56 2010 490 498
20. M.D. Cerqueira, N.J. Weissman, V. Dilsizian Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542
21. R. Hachamovitch, S.W. Hayes, J.D. Friedman, I. Cohen, D.S. Berman Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography Circulation 107 2003 2900 2907
22. R. Hachamovitch, A. Rozanski, L.J. Shaw Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy Eur Heart J 32 2011 1012 1024
23. R.M. Lang, M. Bierig, R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardogr 18 2005 1440 1463
24. P.A. Pellikka, S.F. Nagueh, A.A. Elhendy, C.A. Kuehl, S.G. Sawada American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography J Am Soc Echocardogr 20 2007 1021 1041
25. R. Sicari, P. Nihoyannopoulos, A. Evangelista Stress echocardiography expert consensus statement Eur Heart J 30 2009 278 289
26. E.L. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
27. J.D. Kalbfleisch, R.L. Prentice The Statistical Analysis of Failure Time Data 2nd edition 2002 John Wiley & Sons, Inc. New York, NY
28. D.R. Cox Regression models and life-tables (with discussion) J R Statist Soc B 34 1972 187 220
29. P.E. Carson, A. Miller, C.M. O'Connor Surgical Treatment for Ischemic Heart Failure (STICH) trial: mode of death results (abstr) Eur Heart J 33 Suppl 1 2012 497 498
30. E.J. Velazquez Myocardial imaging should not exclude patients with ischemic heart failure from coronary revascularization Circ Cardiovasc Imaging 5 2012 271 279
31. V. Rizzello, D. Poldermans, A.F.L. Schinkel Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularization Heart 92 2006 239 244